and L. Ackermann, Org. Lett., 2016, 18, 2742; (j) K. R.
Roesch and R. C. Larock, J. Org. Chem., 2002, 67, 86;
(k) Y.-Y. Yang, W.-G. Shou, Z.-B. Chen, D. Hong and
Y.-G. Wang, J. Org. Chem., 2008, 73, 3928; (l) K. R.
Roesch, H. Zhang and R. C. Larock, J. Org. Chem.,
2001, 66, 8042.
Acknowledgement
This work was supported by Grant-in-Aid for
Scientific Research from Japan (JSPS KAKENHI Grant
Number; 15H05803 and 18K14219).
References
9. (a) P. Fernández, C. Valdés, F. J. Faꢀanás and F.
Rodríguez, J. Org. Chem., 2019, 84, 3184; (b) Y. Long,
Z. She, X. Liu and Y. Chen, J. Org. Chem., 2013, 78,
2579; (c) D. Fischer, H. Tomeba, N. K. Pahadi, N. T.
Patil, Z. Huo and Y. Yamamoto, J. Am. Chem. Soc.,
2008, 130, 15720; (d) D. Zheng, S. Li and J. Wu, Org.
Lett., 2012, 14, 2655; (e) Y.-N. Niu, Z.-Y. Yan, G.-L.
Gao, H.-L. Wang, X.-Z. Shu, K.-G. Ji and Y.-M. Liang,
J. Org. Chem., 2009, 74, 2893; (f) G. Dai and R. C.
Larock, J. Org. Chem., 2003, 68, 920; (g) S. Obika, H.
Kono, Y. Yasui, R. Yanada and Y. Takemoto, J. Org.
Chem., 2007, 72, 4462; (h) N. Asao, S. Yudha S., T.
Nogami and Y. Yamamoto, Angew. Chem., Int. Ed.,
2005, 44, 5526; (i) N. Asao, K. Iso and S. Yudha S., Org.
Lett. 2006, 8, 4149; (j) D. Fischer, H. Tomeba, N. K.
Pahadi, N. T. Patil, Z. Huo and Y. Yamamoto, J. Am.
Chem. Soc., 2008, 130, 15720; (k) Q. Huang and R. C.
Larock, J. Org. Chem., 2003, 68, 980; (l) G. Dai and R.
C. Larock, J. Org. Chem., 2002, 67, 7042; (m) Q.
Huang, J. A. Hunter and R. C. Larock, J. Org. Chem.,
2002, 67, 3437; (n) R. Yanada, S. Obika, H. Kono and
Y. Takemoto, Angew. Chem., Int. Ed., 2006, 45, 3822;
(o) G. Dai and R. C. Larock, Org. Lett., 2001, 3, 4035.
10. For examples on heteronickelacycles, see: (a) S. Ogoshi,
H. Ikeda and H. Kurosawa, Angew. Chem., Int. Ed.,
2007, 46, 4930; (b) M. Ohashi, O. Kishizaki, H. Ikeda
and S. Ogoshi, J. Am. Chem. Soc., 2009, 131, 9160; (c)
Y. Hoshimoto, T. Ohata, M. Ohashi and S. Ogoshi,
Chem.-Eur. J., 2014, 20, 4105.
1. K. W. Bentley, The Isoquinoline Alkaloids, vol. 1,
Hardwood Academic, Amsterdam, 1998.
2. (a) D. Kletsas, W. Li, Z. Han and V. Papadopoulos,
Biochem. Pharmacol., 2004, 67, 1927; (b) U. R. Mach,
A. E. Hackling, S. Perachon, S. Ferry, C. G. Wermuth,
J.-C. Schwartz, P. Sokoloff and H. Stark,
ChemBioChem, 2004, 5, 508; (c) F. Dzierszinski, A.
Coppin, M. Mortuaire, E. Dewailly, C. Slomianny, J.-C.
Ameisen, F. DeBels and S. Tomavo, Antimicrob.
Agents Chemother, 2002, 46, 3197.
3. (a) B. W. Trotter, K. K. Nanda, N. R. Kett, C. P. Regan,
J. J. Lynch, G. L. Stump, L. Kiss, J. Wang, R. H.
Spencer, S. A. Kane, R. B. White, R. Zhang, K. D.
Anderson, N. J. Liverton, C. J. McIntyre, D. C. Beshore,
G. D. Hartman and C. J. Dinsmore, J. Med. Chem., 2006
49, 6954; (b) P. Ramesh, N. S. Reddy and Y.
Venkateswarlu, J. Nat. Prod., 1999, 62, 780; (c) C.
Marchand, S. Antony, K. W. Kohn, M. Cushman, A.
Ioanoviciu, B. L. Staker, A. B. Burgin, L. Stewart and
Y. Pommier, Mol. Cancer Ther., 2006, 5, 287.
4. For examples of chiral ligands, see: (a) B. A. Sweetman,
H. Müller-Bunz and P. J. Guiry, Tetrahedron Lett.,
2005, 46, 4643; (b) C. W. Lim, O. Tissot, A. Mattison,
M. W. Hooper, J. M. Brown, A. R. Cowley, D. I.
Hulmes and A. J. Blacker, Org. Process Res. Dev., 2003
7, 379; (c) N. W. Alcock, J. M. Brown and D. I. Hulmes,
Tetrahedron: Asymmetry, 1993, 4, 743.
5. For examples of achiral ligands, see: (a) G. Cheng, P.
Wang and J.-Q. Yu, Angew. Chem., Int. Ed., 2017, 56,
8183; (b) O. M. Kuzmina, A. K. Steib, J. T. Markiewicz,
D. Flubacher and P. Knochel, Angew. Chem., Int. Ed.,
2013, 52, 4945; (c) A. D. Benischke, I. Knoll, A. Rérat,
C. Gosmini and P. Knochel, Chem. Commun., 2016, 52,
3171
,
,
11. (a) Y. Hoshimoto, T. Ohata, Y. Sasaoka, M. Ohashi and
S. Ogoshi, J. Am. Chem. Soc., 2014, 136, 15877; (b) Y.
Hoshimoto, K. Ashida, Y. Sasaoka, R. Kumar, K.
Kamikawa, X. Verdaguer, A. Riera, M. Ohashi and S.
Ogoshi, Angew. Chem., Int. Ed., 2017, 56, 8206.
12. In the presence of Ni(cod)2 (10 mol%)/PCy3 (20 mol%),
the reaction of 1a, phenyl formate (1.5 equiv.), and NEt3
6. For selected reviews, see: (a) M. Balasubramanian and J.
G. Keay, in Comprehensive Heterocyclic Chemistry II,
ed. A. E. McKillop, A. R. Katrizky, C. W. Rees and E.
F. V. Scrivem, Elsevier, Oxford, Vol. 5, 1996, pp. 245-
300. (b) M. Chrzanowska and M. D. Rozwadowska,
Chem. Rev., 2004, 104, 3341.
(2.0
equiv.) furnished a complicated mixture
including 2a as the major product.
13.
7. (a) Chemistry of Heterocyclic Compounds: Isoquinolines,
ed. G. Grethe, John Wiley & Sons, New York, vol. 38,
part 3, 1981. (b) Comprehensive Organic Functional
Group Transformations, 1st ed., ed. A. R. Katritzky and
O. M. Cohn, Pergamon, Chichester U.K., vol. 2 and 3,
1991, pp. 328–419.
8. (a) D. Yang, S. Burugupalli, D. Daniel and Y. Chen, J.
Org. Chem., 2012, 77, 4466; (b) L. Zheng, J. Ju, Y. Bin
and R. Hua, J. Org. Chem., 2012, 77, 5794; (c) R. K.
Chinnagolla, S. Pimparkar and M. Jeganmohan, Org.
Lett., 2012, 14, 3032; (d) S. Zhou, M. Wang, L. Wang,
14. For details, see the Electronic Supplementary Information.
15.(a) X. Xin, D. Wang, X. Li and B. Wan, Angew. Chem.,
Int. Ed., 2012, 51, 1693; (b) Y. Hu, R. Yi, F. Wu and B.
Wan, J. Org. Chem., 2013, 78, 7714; (c) X. Yu, X. Xin,
B. Wan and X. Li, J. Org. Chem., 2013, 78, 4895; (d) Y.
Zhu, W.-T. Lu, H.-C. Sun and Z.-P. Zhan, Org. Lett.,
2013, 15, 4146.
16.In the presence of 20 mol% 1,3-bis(2,6-
diisopropylphenyl)-4,5-dichloroimidazol-2-ylidene, the
formation of an allene compound was confirmed in 15%
K. Chen, J. Wang, C. Song and J. Zhu, Org. Lett., 2016
,
18, 5632; (e) H. Chu, P. Xue, J.-T. Yu and J. Cheng, J.
Org. Chem., 2016, 81, 8009; (f) H. Jiang, J. Yang, X.
Tang and W. Wu, J. Org. Chem., 2016, 81, 2053; (g) M.
1
from 1a in C6D6 at room temperature by H NMR
analysis. This reaction mixture eventually afforded 2a
in 38% yield after 3days, yet the resultant system was
complex.
Tian, G. Zheng, X. Fan and X. Li, J. Org. Chem., 2018
,
83, 6477; (h) Z. Shi, D. C. Koester, M. Boultadakis-
Arapinis and F. Glorius, J. Am. Chem. Soc., 2013, 135,
12204; (i) J. Li, M. Tang, L. Zang, X. Zhang, Z. Zhang